Barely Significant
← all excerpts

Low circulating levels of the mitochondrial-peptide hormone SHLP2: novel biomarker for prostate cancer risk.

Oncotarget · 2017 · PMC5706922 · PMID 29212276

Europe PMCDOI
1
hedged sentence
0.3700
closest p · 7.4× alpha
0.3700
boldest claim

The sentences

approached significancep > 0.37not close (p > 0.1)
On multivariable analysis, lower SHLP2 was linked with increased risk of overall, low-, and high-grade PCa in white men (all p < 0.038), but none of these associations even approached significance in black men (all p > 0.37) (Table 3 ).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.